George Morris

Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines

Paul J. Birrell, K. Lythgoe, D. Bonsall, 2022, Nature Medicine.

Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom

D. Stuart, K. Lythgoe, D. Bonsall, 2021, Nature Microbiology.

Omicron-Associated Changes in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Symptoms in the United Kingdom

D. Clifton, K. Lythgoe, D. Bonsall, 2022, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

SARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infection

K. Lythgoe, D. Bonsall, T. House, 2022, Nature Communications.

Symptoms and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Positivity in the General Population in the United Kingdom

K. Lythgoe, D. Bonsall, T. House, 2021, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

Anti-spike antibody response to natural SARS-CoV-2 infection in the general population

K. Lythgoe, D. Bonsall, T. House, 2021, Nature Communications.

Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK

Paul J. Birrell, K. Lythgoe, D. Bonsall, 2023, Nature communications.

COVID-19 vaccination, risk-compensatory behaviours, and contacts in the UK

K. Lythgoe, D. Bonsall, T. House, 2021, medRxiv.

Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population

K. Lythgoe, D. Bonsall, T. Peto, 2023, medRxiv.

Improving the representativeness of UK’s national COVID-19 Infection Survey through spatio-temporal regression and post-stratification

K. Lythgoe, D. Bonsall, T. House, 2023, medRxiv.

Anti-spike antibody response to natural SARS-CoV-2 infection in the general population

Paul J. Birrell, K. Lythgoe, D. Bonsall, 2021, medRxiv.